SphK2 inhibitors (SphynKx Therapeutics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSphK2 inhibitors (SphynKx Therapeutics)
Drug Alias Namesphingosine kinase-2 inhibitors (SphynKx Therapeutics)SRX-224014SCL-5081308
ClassificationSmall molecules
Mechanisms of ActionSphingosine kinase 2 inhibitors
TargetsSphingosine kinase 2
Therapy Area/IndicationsNerve DegenerationFibrosisAutoimmune Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSphynKx Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSphynKx Therapeutics LLC
Active IndicationsN/A
Inactive IndicationsNerve DegenerationFibrosisAutoimmune Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A